CORE--PROTOCOL SPECIFIC RESEARCH SUPPORT

核心——特定于协议的研究支持

• 批准号: 7311064
• 负责人: L Clarke Cox
• 金额: $ 2.9万
• 依托单位: UNIVERSITY OF HAWAII AT MANOA
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/7311064
• 关键词: biomedical facility; clinical trial phase I; health science research support; neoplasm /cancer

DESCRIPTION (provided by applicant): Information about the feasibility or proof of principle of translational research interventions is supported through the CCSG Protocol-Specific Research mechanism. The Center plans to continue supporting one to three short-term pilot, or Phase I clinical trials each year. Overall Center Protocol-Specific Research activities will be supervised by the Director of the Center's Clinical Trials Unit. The Protocol Specific Research component of the CCSG has been of great importance in enabling new innovative pilot studies in cancer treatment and prevention. Funding for a research nurse has enabled us to establish and maintain research partnerships and operating procedures for working with community practitioners and medical centers. Given the nature of health care delivery to cancer patients in Hawaii, the majority of CRCH-generated studies have been in the Center's high scientific priority areas of cancer prevention and symptom control. As additional clinical research capacity develops over the next few years, we anticipate more projects testing innovative cancer treatments.

描述（由申请人提供）：关于可行性或原理证明的信息 转化研究干预措施是通过CCSG特定方案研究提供支持的 机制该中心计划每年继续支持一到三个短期试点或I期临床试验。总体研究中心方案特定研究活动将由研究中心临床试验部门负责人监督。CCSG的方案特定研究部分在促进癌症治疗和预防的新的创新试点研究方面具有重要意义。为研究护士提供资金使我们能够建立和维护与社区医生和医疗中心合作的研究伙伴关系和操作程序。鉴于夏威夷癌症患者的医疗保健服务性质，CRCH产生的大多数研究都是在该中心的癌症预防和症状控制的高科学优先领域。随着未来几年临床研究能力的发展，我们预计会有更多的项目测试创新的癌症治疗方法。